ES2189386T3 - Nuevo uso de ropivacaina para tratamiento del dolor. - Google Patents

Nuevo uso de ropivacaina para tratamiento del dolor.

Info

Publication number
ES2189386T3
ES2189386T3 ES99903972T ES99903972T ES2189386T3 ES 2189386 T3 ES2189386 T3 ES 2189386T3 ES 99903972 T ES99903972 T ES 99903972T ES 99903972 T ES99903972 T ES 99903972T ES 2189386 T3 ES2189386 T3 ES 2189386T3
Authority
ES
Spain
Prior art keywords
ropivacaine
new use
pain treatment
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99903972T
Other languages
English (en)
Inventor
Goran Isacsson
Dag Selander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2189386T3 publication Critical patent/ES2189386T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Adornments (AREA)

Abstract

Uso de ropivacaína para la fabricación de un medicamento para administración intramuscular en el tratamiento del dolor musculoesquelético.
ES99903972T 1998-01-21 1999-01-11 Nuevo uso de ropivacaina para tratamiento del dolor. Expired - Lifetime ES2189386T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use

Publications (1)

Publication Number Publication Date
ES2189386T3 true ES2189386T3 (es) 2003-07-01

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99903972T Expired - Lifetime ES2189386T3 (es) 1998-01-21 1999-01-11 Nuevo uso de ropivacaina para tratamiento del dolor.

Country Status (11)

Country Link
US (2) US6395291B1 (es)
EP (1) EP1054671B1 (es)
JP (1) JP4456754B2 (es)
AT (1) ATE228840T1 (es)
AU (1) AU2444399A (es)
DE (1) DE69904297T2 (es)
DK (1) DK1054671T3 (es)
ES (1) ES2189386T3 (es)
PT (1) PT1054671E (es)
SE (1) SE9800139D0 (es)
WO (1) WO1999037301A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
EP2209450A4 (en) * 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
US20160030409A1 (en) * 2014-07-30 2016-02-04 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000599A1 (en) 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
WO1998040070A1 (en) 1997-03-13 1998-09-17 Campbell James N Compositions containing capsaicin or capsaicin analogues and a local anesthetic

Also Published As

Publication number Publication date
US20020156101A1 (en) 2002-10-24
EP1054671B1 (en) 2002-12-04
WO1999037301A1 (en) 1999-07-29
DK1054671T3 (da) 2003-02-24
JP4456754B2 (ja) 2010-04-28
SE9800139D0 (sv) 1998-01-21
PT1054671E (pt) 2003-03-31
AU2444399A (en) 1999-08-09
EP1054671A1 (en) 2000-11-29
DE69904297T2 (de) 2003-08-21
US6620423B2 (en) 2003-09-16
US6395291B1 (en) 2002-05-28
ATE228840T1 (de) 2002-12-15
DE69904297D1 (de) 2003-01-16
JP2002501021A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
SE9701161D0 (sv) New use I
BR0016138B1 (pt) formulaÇço farmacÊutica adequada para a administraÇço intranasal, uso de zolmitriptan, e, dispositivo de administraÇço intranasal
SE9802208D0 (sv) Novel compounds
DK1235571T3 (da) Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
DK1294372T3 (da) Törpulverformulering der omdanner racecadotril
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
ES2189386T3 (es) Nuevo uso de ropivacaina para tratamiento del dolor.
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
SE9802209D0 (sv) Novel compounds
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
BR0015938A (pt) Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
ZA9711468B (en) New use of comt inhibitors
DK1150682T3 (da) Ubichinon Qn til behandling af migrænesmerter
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
NO20005548D0 (no) Mykobakterieinhibitorer
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.